Takeda, Cour Partner Wednesday, December 09, 2015 Takeda and Cour have announced a partnership to research and develop novel immune modulating therapies for the potential treatment of celiac disease. New Funding for Ebola Hides an Ongoing Decline Monday, December 07, 2015 A new report gives the first ever picture of global investment in Ebola research and development (R&D), reporting that this investment might have come at the expense of efforts to develop drugs, vaccines and diagnostics for other neglected diseases, which collectively cause more than six million deaths every year in developing countries.Promising New Treatment Joins the War on Superbugs Monday, December 07, 2015 The fight against superbugs has been bolstered thanks to a promising new therapy discovered by University of Adelaide researchers.Liquid Metal ‘Nano-Terminators’ Target Cancer Cells Thursday, December 03, 2015 Researchers at North Carolina State University and the University of North Carolina at Chapel Hill have developed a new drug delivery technique that uses a biodegradable liquid metal to target cancer cells. Teva, Takeda Collaborate Wednesday, December 02, 2015 Teva Pharmaceutical Industries and Takeda Pharmaceutical Company Limited have announced that the two companies have entered into a definitive agreement to establish an unprecedented partnership in Japan.Drug May Prevent Life-Threatening Muscle Loss in Advanced Cancers Wednesday, November 25, 2015 New data describes how an experimental drug can stop life-threatening muscle wasting (cachexia) associated with advanced cancers and restore muscle health. Chemical Design Made Easier Wednesday, November 25, 2015 Rice University scientists prepare elusive organocatalysts for drug and fine chemical synthesis. Pfizer and Allergan to Combine Tuesday, November 24, 2015 This move will create a new global biopharmaceutical leader with best-in-class innovative and established businessesNanocarriers May Carry New Hope for Brain Cancer Therapy Monday, November 23, 2015 Berkeley lab researchers develop nanoparticles that can carry therapeutics across the brain blood barrier.